Lantern Pharma Inc. (LTRN) › Total AssetsLantern Pharma Inc. (LTRN) — Total AssetsAnnual figures by period end, from SEC filings.2019-12-31: $1.43M2020-12-31: $20.36M2021-12-31: $73.95M2022-12-31: $58.84M2023-12-31: $43.65M2024-12-31: $25.57M2025-12-31: $11.04M$11.04M2019-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$11.04M-56.8%2026-03-30Balance as of period end2024-12-31$25.57M-41.4%2026-03-30Balance as of period end2023-12-31$43.65M-25.8%2025-03-27Balance as of period end2022-12-31$58.84M-20.4%2024-03-18Balance as of period end2021-12-31$73.95M+263.2%2023-03-20Balance as of period end2020-12-31$20.36M+1321.2%2022-03-10Balance as of period end2019-12-31$1.43M—2021-03-10Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)